fda glp-1 compounding warning september 2025 Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Beyond the Headlines: FDA Warning

Week 8: Ketosis should be established if carb restriction has been maintained

The new offering, Walgreens Weight Management, operates through the companys virtual healthcare platform and connects adults aged 18 to 64 with licensed physicians and nurse practitioners via online video visits

Foundayo (orforglipron) is a once-daily weight-loss pill manufactured by Eli Lilly that received FDA approval just this past April 1, 2026

AOD 9604 best clinical result was approximately 2.8kg of additional fat loss over 12 weeks, and the larger confirmatory trial (OPTIONS study, 536 subjects, 24 weeks) failed to show statistically significant weight loss compared to placebo